LONDON and BOSTON, May 15, 2014 /PRNewswire via COMTEX/ -- LONDON and BOSTON, May 15, 2014 /PRNewswire/ --
Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, notes that Fiona Marshall, Heptares’ Chief Scientific Officer and co-founder, will give a company presentation at the UBS Global Healthcare Conference in New York City, NY, USA. The presentation will take place at 9:00am EDT on Monday 19 May.
Help employers find you! Check out all the jobs and post your resume.
